본문 바로가기
KERD
논문KCI 등재

Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정신과학

초록

Objective Residual symptoms of depression are related to more severe and chronic course of functional impairment with higher risk of relapse. The objective of this study was to validate, and determine psychometric properties of the Korean version of Depression Residual Symptom Scale (KDRSS). Methods A total of 203 outpatients with recent episode of major depression based on DSM-IV criteria were enrolled in this study. They had been treated with antidepressants and assessed by KDRSS, Hamilton Depression Rating Scale-24 (HDRS-24), and Montgomery-Åsberg Depression Rating Scale (MARDS). The validity and reliability of KDRSS were assessed, including internal consistency reliability, concurrent validity, temporal stability, factorial validity, and discriminative validity. Results Internal consistency (Cronbach’s alpha=0.961), concurrent validity (MADRS: r=0.731, p<0.01, HDRS-24: r=0.663, p<0.01), and temporal stability (r=0.726, p<0.01) of KDRSS were all excellent. KDRSS showed good discriminative validity based on MARDS. KDRSS consisted of one-factor structure accounting for 63.8% of total variance. All subjects except two in full remission group had one or more residual symptoms. In 7 subscales of KDRSS consisting of similar items respectively, ‘lack of energy’ was the most commonly reported, followed by ‘increased emotionalism’ in this group. Conclusion KDRSS is a useful and sensitive instrument for measuring residual depressive symptoms. Since some depressive symptoms including ‘lack of energy’ and ‘increased emotionalism’ in patients with full remission might be persistent during psychiatric intervention, these symptoms need to be focused on in clinical practice.

Abstract

Objective Residual symptoms of depression are related to more severe and chronic course of functional impairment with higher risk of relapse. The objective of this study was to validate, and determine psychometric properties of the Korean version of Depression Residual Symptom Scale (KDRSS). Methods A total of 203 outpatients with recent episode of major depression based on DSM-IV criteria were enrolled in this study. They had been treated with antidepressants and assessed by KDRSS, Hamilton Depression Rating Scale-24 (HDRS-24), and Montgomery-Åsberg Depression Rating Scale (MARDS). The validity and reliability of KDRSS were assessed, including internal consistency reliability, concurrent validity, temporal stability, factorial validity, and discriminative validity. Results Internal consistency (Cronbach’s alpha=0.961), concurrent validity (MADRS: r=0.731, p<0.01, HDRS-24: r=0.663, p<0.01), and temporal stability (r=0.726, p<0.01) of KDRSS were all excellent. KDRSS showed good discriminative validity based on MARDS. KDRSS consisted of one-factor structure accounting for 63.8% of total variance. All subjects except two in full remission group had one or more residual symptoms. In 7 subscales of KDRSS consisting of similar items respectively, ‘lack of energy’ was the most commonly reported, followed by ‘increased emotionalism’ in this group. Conclusion KDRSS is a useful and sensitive instrument for measuring residual depressive symptoms. Since some depressive symptoms including ‘lack of energy’ and ‘increased emotionalism’ in patients with full remission might be persistent during psychiatric intervention, these symptoms need to be focused on in clinical practice.

참고문헌 (34)

  1. Kupfer DJ, "Refractory depression: prediction of non-response by clinical indicators", J Clin Psychiatry, 42, pp.307~312 (1981)
  2. McClintock SM, "Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication", J Clin Psychopharmacol, 31, pp.180~186 (2011)[DOI]
  3. Israel JA, "The impact of residual symptoms in major depression", Pharmaceuticals (Basel), 3, pp.2426~2440 (2010)[DOI]
  4. Judd LL, "Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse", J Affect Disord, 50, pp.97~108 (1998)[DOI]
  5. Judd LL, "Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?", Am J Psychiatry, 157, pp.1501~1504 (2000)[DOI]
  6. Keller MB, "Past, present, and future directions for defining optimal treatment outcome in depression: remission and beyond", JAMA, 289, pp.3152~3160 (2003)[DOI]
  7. Yang H, "Type of residual symptom and risk of relapse during the continuation", maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine, 2010, pp.260, 145~150
  8. Bakish D, "New standard of depression treatment: remission and full recovery", J Clin Psychiatry, 62(Suppl 26), pp.5~9 (2001)
  9. Boulenger JP, "Residual symptoms of depression: clinical and theoretical implications", Eur Psychiatry, 19, pp.209~213 (2004)[DOI]
  10. Cornwall PL, "Partial remission in depressive disorders", Acta Psychiatr Scand, 95, pp.265~271 (1997)[DOI]
  11. Fava GA, "Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications", Psychol Med, 29, pp.47~61 (1999)[DOI]
  12. Zimmerman M, "Heterogeneity among depressed outpatients considered to be in remission", Compr Psychiatry, 48, pp.113~117 (2007)[DOI]
  13. Trivedi MH, "Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission", J Clin Psychiatry, 70(Suppl 6), pp.26~31 (2009)[DOI]
  14. Bertschy G, "Self-rated residual symptoms do not predict 1-year recurrence of depression", Eur Psychiatry, 25, pp.52~57 (2010)
  15. Zimmerman M, "How should remission from depression be defined? The depressed patient's perspective", Am J Psychiatry, 163, pp.148~150 (2006)[DOI]
  16. Alexopoulos GS, "Remission in depressed geriatric primary care patients: a report from the PROSPECT study", Am J Psychiatry, 162, pp.718~724 (2005)[DOI]
  17. Montgomery SA, "A new depression scale designed to be sensitive to change", Br J Psychiatry, 134, pp.382~389 (1979)[DOI]
  18. Bernstein IH, "A comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an adult outpatient clinical sample", CNS Spectr, 15, pp.458~468 (2010)[DOI]
  19. Carmody TJ, "The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures", Eur Neuropsychopharmacol, 16, pp.601~611 (2006)[DOI]
  20. Uher R, "Measuring depression: comparison and integration of three scales in the GENDEP study", Psychol Med, 38, pp.289~300 (2008)
  21. Fava M, "Somatic symptoms, depression, and antidepressant treatment", J Clin Psychiatry, 63, pp.305~307 (2002)[DOI]
  22. Moller HJ, "Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale", Eur Arch Psychiatry Clin Neurosci, 251(Suppl 2), pp.13~20 (2001)[DOI]
  23. Suhr D, "Principle Component Analysis versus Exploratory Factor Analysis" (2005), SUGI 30 (SAS Users Group International)
  24. Slocum-Gori SL, "Assessing the unidimensionality of psychological scales: using multiple criteria from factor analysis", Soc Indic Res, 102, pp.443~461 (2011)[DOI]
  25. Snaith RP, "Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales", Br J Psychiatry, 148, pp.599~601 (1986)[DOI]
  26. Klopf DW, "Intercultural Encounters: The Fundamentals of Intercultural Communication" (1998), Morton Publishing Company
  27. Javidi A, "Cross-cultural analysis of interpersonal bonding: a look at East and West", Howard J Commun, 3, pp.129~138 (1991)[DOI]
  28. Markus HR, "Culture and the self: implications for cognition, emotion, and motivation", Psychol, 98, pp.224~ (1991)
  29. Duggan C, "Neuroticism: a vulnerability marker for depression evidence from a family study", J Affect Disord, 35, pp.139~143 (1995)[DOI]
  30. Steunenberg B, "Personality and the onset of depression in late life", J Affect Disord, 92, pp.243~251 (2006)[DOI]
  31. Demyttenaere K, "The many faces of fatigue in major depressive disorder", Int J Neuropsychopharmacol, 8, pp.93~105 (2005)[DOI]
  32. 전상원, "외상후 성장 및 리질리언스 평가와 임상적 의의", 신경정신의학, 54(1), pp.32~39 (2015), 대한신경정신의학회[DOI]
  33. Masten AS, "Resilience and development: contributions from the study of children who overcome adversity", Dev Psychopathol, 2, pp.425~444 (1990)[DOI]
  34. Linden M, "Posttraumatic embitterment disorder", Psychother Psychosom, 72, pp.195~202 (2003)[DOI]

관련 논문AI추천

한글판 우울증 관해 질문지의 표준화 예비 연구김민경, 김정범, 김희철, 신예니, 조현주대한불안의학회 · 대한불안의학회지2014 · 제10권 제2호Measurement-based Treatment of Residual Symptoms Using Clinically Useful Depression Outcome Scale: Korean Validation StudyAshwin A. Patkar, Changsu Han, Chi-Un Pae, Ho-Kyoung Yoon, Jong Woo Kim, Joonho Choi, Mark Zimmerman, Sang Won Jeon, Seoyoung Yoon, Seung-Duk Ko, Yong Chon Park, Young-Hoon Ko대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2017 · 제15권 제1호The Symptom Frequency Characteristics of the Hamilton Depression Rating Scale and Possible Symptom Clusters of Depressive Disorders in Korea: The CRESCEND Study김재민, 이민수, 전태연, Jung Bum Kim, Sae-Heon Jang, Seung Hee Jeong, Young-Myo Jae, Young-Nam Park대한신경정신의학회 · PSYCHIATRY INVESTIGATION2011 · 제8권 제4호Development of a Korean Version of the Perceived Deficits Questionnaire-Depression for Patients with Major Depressive Disorder강희주, 김상대, 김재민, 이용성, 홍진표대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2016 · 제14권 제1호한국판 우울과 신체 증상 평가 척도(Depression and Somatic Symptom Scale, DSSS)의 신뢰도와 타당도김건우, 박승진, 최지혜, 최혜라, 홍진표대한불안의학회 · 대한불안의학회지2011 · 제7권 제1호Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders김재민, Ha-Yeon Kim, Hee-Joon Lee, Hee-Ju Kang, Il-Seon Shin, Ju-Wan Kim, Ju-Yeon Lee, Min Jhon, Sung-Wan Kim대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제3호

이 간행물의 다른 논문 (19건)